Airway Clearance Systems Market Expected To Witness A Substantial Growth Of $698.11 Million By 2026: Grand View Research Inc.

The global airway clearance systems market size is expected to reach USD 698.11 million by 2026, registering a CAGR of 4.5% over the forecast period, according to a new report by Grand View Research, Inc. The airway or mucus clearance devices are majorly used for the treatment of various respiratory diseases. Rising adoption of clearance system to curb the surmounting prevalence of cystic fibrosis, Chronic Obstructive Pulmonary Disease (COPD), bronchiectasis is the primary market driver.

According to the U.S. Department of Health and Human Services, About 1 in every 2,500 to 3,500 Caucasian babies is diagnosed with cystic fibrosis in U.S. This ratio significantly lower among Asian and African Americans at 1 in 31,000 and 17,000 births, respectively. This factor is expected to contribute to the product demand over the forecast period. Breakthroughs in airway clearance systems are anticipated to positively influence the market. For instance, as manufactured by Dymedso, a digitally controlled acoustic airway clearance device endorses bronchial drainage by inducing vibration in the thoracic walls. Leading to a less painful and more effective treatment. Groundbreaking technological advancements are rapidly transforming the airway clearance devices, creating new growth opportunities.

Key players operating in the airway clearance systems market are Hill-Rom Holdings, Inc.; Electromed Inc.; Aptalis Pharma U.S. Inc.; and Thayer Medical. These players account for a significant market share, owing to their broad product offerings. Microsoft, Great Ormond Street Hospital, and University College London have collaborated to develop Project Fizzyo, to make the cystic fibrosis treatment more enjoyable for the children. This project gamifies the treatment with the help of innovative technology. Major market players are focusing on increasing their brand penetration and acceptance by collaborating with insurance companies. For instance, under Patient Assistance Program, Hill-Rom offers access to VitalCough System and Vest Airway Clearance System for reducing the financial burden from the eligible patients.

Download Free Sample Report @

https://www.grandviewresearch.com/industry-analysis/airway-clearance-systems-market/request/rs1

As per the World Health Organization (WHO) report published in 2019, COPD is the third leading cause of death globally. Cystic Fibrosis (CF) is a life-shortening genetic disorder that affects many organs, mainly the lungs. It is assessed heterozygote frequency in white people is up to one in every 20. In the U.K. alone there had been a sharp rise in the CF patient registry from 10,338 (2012) till 10,509 (2018) as recorded by the Cystic Fibrosis Trust in 2019. This is anticipated to increase the adoption of airway clearance systems in the near future.

 

Airway Clearance Systems Market Report Highlights

• Flutter mucus clearance device held the dominant market share in 2018 due to cost effectiveness, ease of use, and easy portability of the product
• Cystic fibrosis segment held the largest market share in 2018 and is anticipated to witness significant CAGR over the forecast period due to growing patient population and available of patient care support
• Home care settings held the dominant market share in 2018 mainly due to ease of therapy accessed from the comfort of home
• Hill-Rom Holdings, Inc.; Electromed Inc.; Aptalis Pharma U.S. Inc.; and Thayer Medical are some of the major market player

Some of the prominent players in the airway clearance systems market include:

• Hill-Rom Holdings Inc.
• Electromed Inc.
• Philips Respironics
• General Physiotherapy Inc.

Grand View Research has segmented the global airway clearance systems market on the basis of the device type, application, end use:

Airway Clearance Systems Device Type Outlook (Revenue, USD Million, 2014 - 2026)

• Positive Expiratory Pressure (PEP)
• Flutter Mucus Clearance Device
• High Frequency Chest Wall Oscillation (HFCWO)
• Intrapulmonary Percussive Ventilation (IPV)
• Others

Airway Clearance Systems Application Outlook (Revenue, USD Million, 2014 - 2026)

• Cystic Fibrosis
• Neuromuscular
• Bronchiectasis
• Others (Immotile Cilia Syndrome, Chronic Bronchitis)

Airway Clearance Systems End Use Outlook (Revenue, USD Million, 2014 - 2026)

• Hospitals & Clinics
• Home Care Settings
• Ambulatory Surgical Centers
• Others